EGFR and neoplasm: Therefore, the detection of ctDNA EGFRm could reflect the accurate molecular status of the primary tumor, and the plasma EGFR test could be a useful screening tool for the diagnosis of NSCLC when tumor tissue is insufficient or tumor genotyping is not feasible.